Showing results (521-530 of 773) with videos related to
Sort By:
Pageof 78
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 6, 1999
Proton dosimetry intercomparison based on the ICRU report 59 protocolS Vatnitsky, M Moyers, D Miller, et al.Infection and Immunity|February 4, 2010
Testing the efficacy and toxicity of adenylyl cyclase inhibitors against enteric pathogens using in vitro and in vivo models of infectionScott T Moen, Carla A Blumentritt, Terry M Slater, et al.Bioorganic & Medicinal Chemistry Letters|May 22, 2012
Sulfonyl-morpholino-pyrimidines: SAR and development of a novel class of selective mTOR kinase inhibitorM Raymond V Finlay, David Buttar, Susan E Critchlow, et al.Medical and Pediatric Oncology|May 2, 2002
In vitro drug resistance profile of Philadelphia positive acute lymphoblastic leukemia is heterogeneous and related to age: a report of the Dutch and German Leukemia Study GroupsN L Ramakers-van Woerden, R Pieters, D Hoelzer, et al.Journal of the Society for Cardiovascular Angiography & Interventions|April 15, 2025
Generating Risk Reduction Analytics in Complex Cardiac Care Environments (GR2AC3E): Risk Prediction in Congenital CatheterizationBrian P Quinn, Lauren C Gunnelson, Alex Case, et al.British Journal of Haematology|March 22, 2001
In vitro drug resistance and prognostic impact of p16INK4A/P15INK4B deletions in childhood T-cell acute lymphoblastic leukaemiaN L Ramakers-van Woerden, R Pieters, R M Slater, et al.The Pediatric Infectious Disease Journal|May 11, 2026
Community-acquired Pneumonia in Bangladeshi Children Under Five: Pathogen Prevalence, Resistance Trends, and Diagnostic BiomarkersSanchita Kar, Sharmin Aktar Mukta, Zannat Kawser, et al.Blood|July 27, 2000
TEL/AML1 gene fusion is related to in vitro drug sensitivity for L-asparaginase in childhood acute lymphoblastic leukemiaN L Ramakers-van Woerden, R Pieters, A H Loonen, et al.Leukemia|June 22, 2001
t(7;12)(q36;p13) and t(7;12)(q32;p13)--translocations involving ETV6 in children 18 months of age or younger with myeloid disordersR M Slater, E von Drunen, W G Kroes, et al.Leukemia|February 3, 1998
Detection of CBP rearrangements in acute myelogenous leukemia with t(8;16)R H Giles, J G Dauwerse, C Higgins, et al.Pageof 78